[1] Williams A, Syed S, Velangi S, et al. New directions in vulvar cancer pathology[J]. Curr Oncol Rep, 2019, 21(10):88. DOI: 10.1007/s11912-019-0833-z.
[2] 中国抗癌协会妇科肿瘤专业委员会.外阴恶性肿瘤诊断和治疗指南(2021年版)[J].中国癌症杂志,2021,31(6):533-545.DOI:10.19401/j.cnki.1007-3639.2021.06.11.
[3] 李海金.外阴癌病因及发病机制研究[J].实用妇产科杂志,2012,28(9):729-731.DOI:10.3969/j.issn.1003-6946. 2012.09.010.
[4] Zhang M, Wang Y, Wang Y, et al. Association between Systemic Lupus Erythematosus and cancer morbidity and mortality: findings from cohort studies[J]. Front Oncol, 2022, 12:860794. DOI: 10.3389/fonc.2022.860794.
[5] 赵平,古金华.系统性红斑狼疮合并恶性肿瘤的临床分析[J].当代医学,2016,22(28):92-93.DOI:10.3969/j.issn.1009-4393.2016.28.062.
[6] 李艳芳,李孟达.外阴上皮内瘤变与外阴癌的病因学研究进展[J].中国实用妇科与产科杂志,2001,17(11):647-648.DOI:10.3969/j.issn.1005-2216.2001.11.004.
[7] Wang L, Zhang Q, Shi N, et al. Case report: synchronous tumors of the female reproductive tract in systemic lupus erythematosus: report of two cases and review of the literature[J]. Front Oncol, 2024, 14:1322598. DOI: 10.3389/fonc.2024.1322598.
[8] Stepanić V, Corusić A, Matković V, et al. Vulvar intraepithelial neoplasia in a young woman with systemic lupus erythematosus: a case report[J]. Lupus, 2010, 19(1):96-99. DOI: 10.1177/0961203309345742.
[9] Dreyer L, Faurschou M, Mogensen M, et al. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort[J]. Arthritis Rheum, 2011, 63(10):3032-3037. DOI: 10.1002/art.30483.
[10] Goobie GC, Bernatsky S, Ramsey-Goldman R, et al. Malignancies in systemic lupus erythematosus: a 2015 update[J]. Curr Opin Rheumatol, 2015, 27(5):454-460. DOI: 10.1097/BOR.0000000000000202.
[11] 于水莲,陶怡,黄文辉,等.Toll样受体7在系统性红斑狼疮合并高危人乳头瘤病毒感染中的作用[J].广东医学,2016,37(2):236-241.DOI:10.13820/j.cnki.gdyx.2016.02.018.
[12] 唐翔,陶怡,黄文辉,等.Toll 样受体9在系统性红斑狼疮患者高人乳头瘤病毒感染中的作用[J].贵州医药,2016,40(6):575-580.DOI:10.3969/j.issn.1000-744X.2016.06.005.
[13] Mendoza-Pinto C, Garcia-Carrasco M, Vallejo-Ruiz V, et al. The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus[J]. Clinics (Sao Paulo), 2013, 68(12):1475-1480. DOI: 10.6061/clinics/2013(12)01.
[14] Tam LS, Chan AY, Chan PK, et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection[J]. Arthritis Rheum, 2004, 50(11):3619-3625. DOI: 10.1002/art.20616.
[15] Klumb EM, Pinto AC, Jesus GR, et al. Are women with lupus at higher risk of HPV infection?[J]. Lupus, 2010, 19(13):1485-1491. DOI: 10.1177/0961203310372952.
[16] 李浩,李江涛,刘丹,等.贝利尤单抗治疗系统性红斑狼疮患者的疗效及安全性的meta分析[J].国际医药卫生导报,2023,29(22):3181-3188.DOI:10.3760/cma.j.issn.1007- 1245.2023.22.019.
[17] 宗世华,孙永华,尉世同.白芍总苷胶囊联合他克莫司胶囊治疗系统性红斑狼疮的疗效[J].国际医药卫生导报,2023,29(3):424-427.DOI:10.3760/cma.j.issn.1007-1245.2023. 03.028.
[18] Olawaiye AB, Cuello MA, Rogers LJ. Cancer of the vulva: 2021 update[J]. Int J Gynaecol Obstet, 2021, 155Suppl 1(Suppl 1):7-18. DOI: 10.1002/ijgo.13881.
[19] 丁岩,张梦蕾,丁景新,等.外阴癌腹股沟淋巴结清扫术的研究新进展[J].中国计划生育和妇产科,2019,11(10):24-29.DOI:10.3969/j.issn.1674-4020.2019.10.07.
[20] Merlo S. Modern treatment of vulvar cancer[J]. Radiol Oncol, 2020, 54(4):371-376. DOI: 10.2478/raon-2020- 0053.
[21] 中国优生科学协会阴道镜和子宫颈病理学分会,中华医学会妇科肿瘤学分会,中国抗癌协会妇科肿瘤专业委员会,等.中国子宫颈癌筛查指南(一)[J].现代妇产科进展,2023,32(7):481-487.DOI:10.13283/j.cnki.xdfckjz.2023.07.001.
[22] Grein IH, Groot N, Lacerda MI, et al. HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know[J]. Pediatr Rheumatol Online J, 2016, 14(1):12. DOI: 10.1186/s12969-016-0072-x.
[23] 王银浩,谢通,刘栩.女性系统性红斑狼疮患者HPV感染特点及疫苗安全性的研究现状[J].现代妇产科进展,2018,27(6):462-464.DOI:10.13283/j.cnki.xdfckjz.2018.06.015.
[24] 罗雅娟,王丹丹,杨清.HPV致女性生殖道疾病及HPV疫苗现况[J].国际生殖健康/计划生育杂志,2019,38(3):244-248.DOI:10.3969/j.issn.1674-1889.2019.03.016.
[25] Pellegrino P, Radice S, Clementi E. Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: a systematic review[J]. Vaccine, 2015, 33(30):3444-3449. DOI: 10.1016/j.vaccine.2015.05.041.
|